An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.
Clinical trial NCT03909295 · TERMINATED
Trial details
- NCT number
- NCT03909295
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2019-11-19
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.